Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 9, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 17, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 27, 2026 | May 26, 2026 |
| 8-K |
Current report
Agreement ended
|
May 15, 2026 | May 11, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Mar 26, 2026 | Mar 20, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 18, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 17, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 6, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 5, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Other events
|
Feb 5, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Listing notice
|
Jan 16, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 25, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 14, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 31, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2025 | Oct 26, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 17, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 1, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Sep 15, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 10, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Aug 29, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Agreement ended
|
Aug 20, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 7, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Aug 4, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 11, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 26, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 1, 2025 | Apr 27, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 29, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 21, 2023 | Apr 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 24, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Aug 9, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 12, 2022 | Jun 24, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 16, 2022 | May 13, 2022 |
| 8-K |
Current report
Other events
|
Mar 16, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Mar 10, 2022 | Mar 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 7, 2021 | Dec 3, 2021 |
| 8-K |
Current report
Listing notice, Bylaw or fiscal year change
|
Sep 17, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 26, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 20, 2021 | Jul 16, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 15, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 9, 2021 | Apr 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2021 | Mar 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 17, 2021 | Feb 12, 2021 |
| 8-K |
Current report
Other events
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Dec 4, 2020 | Dec 3, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 2, 2020 | Nov 30, 2020 |
| 8-K |
Current report
Listing notice
|
Nov 20, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 14, 2020 | Oct 9, 2020 |
| 8-K |
Current report
Other events
|
Jul 14, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Other events
|
Jun 26, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 15, 2020 | Apr 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2020 | Mar 6, 2020 |
| 8-K |
Current report
Other events
|
Feb 7, 2020 | Feb 5, 2020 |
| 8-K |
Current report
Results of operations
|
Jan 14, 2020 | Jan 14, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2019 | Dec 2, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2019 | Nov 14, 2019 |
| 8-K |
Current report
Officer or director change
|
Sep 6, 2019 | Aug 30, 2019 |
| 8-K |
Current report
Results of operations
|
Jul 15, 2019 | Jul 15, 2019 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Jun 25, 2019 | Jun 21, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 30, 2019 | Apr 24, 2019 |
| 8-K |
Current report
Other events
|
Mar 8, 2019 | Mar 6, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2019 | Mar 1, 2019 |
| 8-K |
Current report
Other events
|
Oct 9, 2018 | Oct 9, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 14, 2018 | Sep 12, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 30, 2018 | May 30, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 1, 2018 | Jan 26, 2018 |
| 8-K |
Current report
Material agreement
|
Jan 19, 2018 | Jan 18, 2018 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 27, 2017 | Dec 20, 2017 |
| 8-K |
Current report
Material agreement
|
Dec 22, 2017 | Dec 20, 2017 |
| 8-K/A | Amended current report | Oct 3, 2017 | Jul 31, 2017 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2017 | Sep 20, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Aug 4, 2017 | Jul 31, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
May 16, 2017 | May 11, 2017 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
May 8, 2017 | May 2, 2017 |
| 8-K |
Current report
Other events
|
May 2, 2017 | May 2, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 17, 2017 | Apr 14, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Apr 7, 2017 | Mar 22, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 10, 2017 | Feb 10, 2017 |
| 8-K |
Current report
Other events
|
Feb 6, 2017 | Jan 19, 2017 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change
|
Nov 18, 2016 | Nov 18, 2016 |
| 8-K |
Current report
Agreement ended
|
Sep 7, 2016 | Sep 1, 2016 |
| 8-K |
Current report
Material agreement
|
Jul 13, 2016 | Jul 12, 2016 |
| 8-K |
Current report
Auditor change
|
Jul 9, 2015 | Jul 6, 2015 |
Showing 99 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.